RECOMBINANT-HUMAN-ERYTHROPOIETIN REDUCES FREE ERYTHROCYTE PROTOPORPHYRIN LEVELS IN PATIENTS ON CHRONIC DIALYSIS

被引：16
|
作者：
PIAZZA, V
VILLA, G
GALLI, F
SEGAGNI, S
BOVIO, G
POGGIO, F
PICARDI, L
SALVADEO, A
机构：
[1] Div. di Nefrologia ed Emodiali, Fondazione Clinica del Lavoro, I-27100 Pavia
来源：
NEPHRON | 1992年 / 61卷 / 01期
关键词：
ERYTHROPOIETIN; HEME; HEMODIALYSIS; PORPHYRINS;
D O I：
10.1159/000186834
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We studied the significance of free erythrocyte protoporphyrin (FEP) in relation to iron status, aluminum levels and anemia in uremic patients on chronic dialysis. All but 1 patient showed high FEP values closely related to the degree of anemia. Increased FEP levels are due to a defective heme synthesis, not related to iron deficiency or aluminum overload. Treatment of anemia with recombinant human erythropoietin reduced FEP values. We therefore hypothesize that recombinant human erythropoietin ameliorates an enzymatic defect in heme synthesis.
引用
收藏
页码：54 / 57
页数：4
相关论文
共 50 条
  • [31] THE TREATMENT OF RENAL ANEMIA IN CAPD PATIENTS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    MACDOUGALL, IC
    DAVIES, ME
    HUTTON, RD
    CAVILL, I
    LEWIS, NP
    COLES, GA
    WILLIAMS, JD
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (11) : 950 - 955
  • [32] EVALUATION OF PLATELET HYPERFUNCTION IN HEMODIALYSIS-PATIENTS RECEIVING RECOMBINANT-HUMAN-ERYTHROPOIETIN
    ZIRKMAN, DM
    ZEIGLER, ZR
    FRALEY, DS
    BRUNS, FJ
    ADLER, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (01) : 31 - 37
  • [33] INTRAVENOUS VERSUS SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS ON HEMODIALYSIS AND CAPD
    EIDEMAK, I
    FRIEDBERG, MO
    LADEFOGED, SD
    LOKKEGAARD, H
    PEDERSEN, E
    SKIELBOE, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (06) : 526 - 529
  • [34] PHARMACOKINETICS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CHILDREN TREATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    REDDINGIUS, RE
    SCHRODER, CH
    KOSTER, AM
    MONNENS, LAH
    EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (11) : 850 - 854
  • [35] INTRAPERITONEAL ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CHILDREN ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    REDDINGIUS, RE
    SCHRODER, CH
    MONNENS, LAH
    EUROPEAN JOURNAL OF PEDIATRICS, 1992, 151 (07) : 540 - 542
  • [36] PREPARATION OF IODINE LABELED RECOMBINANT-HUMAN-ERYTHROPOIETIN
    KINOSHITA, H
    OHISHI, N
    OKAZAKI, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1991, 41-1 (05): : 568 - 570
  • [37] RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN PEDIATRIC-PATIENTS RECEIVING LONG-TERM PERITONEAL-DIALYSIS
    WARADY, BA
    SABATH, RJ
    SMITH, CA
    ALON, U
    HELLERSTEIN, S
    PEDIATRIC NEPHROLOGY, 1991, 5 (06) : 718 - 723
  • [38] TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    HELLSTROM, E
    BIRGEGARD, G
    LOCKNER, D
    HELMERS, C
    OST, A
    WIDE, L
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 47 (05) : 355 - 360
  • [39] RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF THE ANEMIA OF CANCER
    ABELS, RI
    ACTA HAEMATOLOGICA, 1992, 87 : 4 - 11
  • [40] PLASMA-CONCENTRATIONS OF IMMUNOREACTIVE-ENDOTHELIN IN PATIENTS WITH CHRONIC-RENAL-FAILURE TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    TAKAHASHI, K
    TOTSUNE, K
    IMAI, Y
    SONE, M
    NOZUKI, M
    MURAKAMI, O
    SEKINO, H
    MOURI, T
    CLINICAL SCIENCE, 1993, 84 (01) : 47 - 50
12345